
Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock
The current stock price of NZM2.DE is 53.2 EUR. In the past month the price decreased by -2.85%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.25B | ||
| SY1.DE | SYMRISE AG | 19.75 | 10.02B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.36 | 9.56B | ||
| AKU1.DE | AKZO NOBEL N.V. | 15.14 | 9.43B | ||
| SYENS.BR | SYENSQO SA | 21.58 | 7.29B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.71 | 6.16B | ||
| AKE.PA | ARKEMA | 10.14 | 3.97B | ||
| UMI.BR | UMICORE | 13.47 | 3.75B | ||
| NVJP.DE | UMICORE | 12.81 | 3.57B | ||
| WCH.DE | WACKER CHEMIE AG | 153.02 | 3.43B | ||
| RBT.PA | ROBERTET SA | 18.76 | 1.91B | ||
| ACT.DE | ALZCHEM GROUP AG | 21.11 | 1.31B |
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
NOVONESIS (NOVOZYMES) B
Krogshoejvej 36
Bagsvaerd DK
Employees: 10582
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
The current stock price of NZM2.DE is 53.2 EUR. The price decreased by -0.67% in the last trading session.
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.63%. The yearly dividend amount is currently 0.67.
NZM2.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
NZM2.DE stock is listed on the Frankfurt Stock Exchange exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-02-25, after the market close.
ChartMill assigns a technical rating of 3 / 10 to NZM2.DE.
ChartMill assigns a fundamental rating of 5 / 10 to NZM2.DE. While NZM2.DE has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.51. The EPS decreased by -54.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.61% | ||
| ROA | 4.31% | ||
| ROE | 6.54% | ||
| Debt/Equity | 0.26 |
22 analysts have analysed NZM2.DE and the average price target is 64.14 EUR. This implies a price increase of 20.56% is expected in the next year compared to the current price of 53.2.
For the next year, analysts expect an EPS growth of 44.46% and a revenue growth 5.74% for NZM2.DE